MAPK3 and malignant colon neoplasm: Within this research, butyrate inhibited the phosphorylation of ERK1/2 in all three colon cancer cell lines (Figure 3), which suggests that butyrate may reduce survival signaling in colon cancer cells and increase subsequent cell apoptosis (Figure 2).